Publicis creates Halo around RM, interactive

Share this article:
Publicis Healthcare Communications Group, a division of Paris-based Publicis Groupe, announced the creation of Halo, an advertising agency specializing in interactive and relationship marketing.
Halo will be based in New York and led by managing director Rebecca Sroge, formerly EVP of Saatchi & Saatchi Consumer Healthcare CRM, along with creative director Norbert Fructeau de Laclos.

“The name Halo captures the spirit and mission of our new agency,” explained Sroge. “Our services look to an integrated approach that drives synergy and added value, creating a ‘halo' effect from our core efforts.

“Halo also is a military acronym for High Altitude, Low Opening, referring to a type of very strategic skydiving. Finding that window of opportunity and timing your CRM efforts makes the difference between success and failure.”

Halo's service offerings will include strategic planning, brand development, database marketing, advertising, direct marketing and interactive communications.

The new agency will report into Mike Trepicchio, CEO of Saatchi & Saatchi Healthcare Communications.

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Channel

Email Newsletters

MM&M Future Leaders


Register now

Early bird $1,950 before 31 October 2014

*Group discounts available on request 

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Channel

Five things for pharma marketers to know: Monday, September 15

Five things for pharma marketers to know: ...

Pharma has sought 76 meetings with FDA over biosimilars; Gilead licenses Sovaldi to India generic drugmakers; Pfizer and Ranbaxy Lipitor lawsuit dismissed.

Liraglutide, aiming for new indication, gets new name

Liraglutide, aiming for new indication, gets new name

Why Novo Nordisk is choosing not to leverage Victoza's brand equity as it seeks a weight-loss indication for liraglutide.

Five things for pharma marketers to know: Friday, September 12

Five things for pharma marketers to know: Friday, ...

An FDA panel voted in favor of liraglutide for weight loss; Allergan investors backing an attempted takeover of the firm crossed a critical threshold; and 100 million health wearables are ...